Shenzhen Huishan Biotechnology Co., Ltd.

This early-stage trial tests a new stem cell injection made from umbilical cord cells for people with systemic sclerosis, a rare disease that causes skin hardening and organ damage. About 21 adults with recent-onset diffuse disease will receive the treatment to check its safety a…

This early-phase trial tests a new stem cell treatment (HS_SW01) for people with ankylosing spondylitis, a type of arthritis that causes spine pain and stiffness. The study will include 18 adults aged 18 to 65. Researchers aim to check if the treatment is safe and if it helps red…

This early-phase trial tests a stem cell injection (HS_SW01) in 21 women with primary ovarian insufficiency (POI), a condition where ovaries stop working before age 40. The main goal is to check safety and see if the treatment can improve hormone levels linked to ovarian function…